These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1647850)

  • 1. The interaction of 3,5-pyrazolidinedione drugs with receptors for f-Met-Leu-Phe on human neutrophil leukocytes: a study of the structure-activity relationship.
    Levesque L; Gaudreault RC; Marceau F
    Can J Physiol Pharmacol; 1991 Mar; 69(3):419-25. PubMed ID: 1647850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two classes of non-peptide drugs as antagonists of neutrophil receptors for f-Met-Leu-Phe. Pyrazolons and iodinated radiographic contrast agents.
    Levesque L; Gaudreault RC; Marceau F
    Biochem Pharmacol; 1992 Feb; 43(3):553-60. PubMed ID: 1311583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute ethanol intoxication regulates f-met-leu-phe-induced chemotaxis and superoxide release by neutrophils and Kupffer cells through modulation of the formyl peptide receptor in the rat.
    Bautista AP; Elliott KE
    Life Sci; 1994; 54(11):721-30. PubMed ID: 8107522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Countergradients of nonchemotactic ligands for N-formylmethionylleucylphenylalanine (FMLP) receptors promote FMLP-induced chemotaxis.
    Gray GD; Ohlmann GM
    Proc Soc Exp Biol Med; 1986 Feb; 181(2):256-62. PubMed ID: 2868456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
    Rotrosen D; Malech HL; Gallin JI
    J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L; Aksamit RR
    J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of binding of a potent chemotactic formyl tetrapeptide, formylmethionyl-leucyl-phenylalanyl-phenylalanine, to the receptors on rabbit neutrophils.
    Kermode JC; Muthukumaraswamy N; Freer RJ
    J Leukoc Biol; 1988 May; 43(5):420-8. PubMed ID: 2836540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils.
    Atkinson YH; Lopez AF; Marasco WA; Lucas CM; Wong GG; Burns GF; Vadas MA
    Immunology; 1988 Jul; 64(3):519-25. PubMed ID: 2842255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.
    Charest-Morin X; Roy C; Fernandes MJ; Marceau F
    Int Immunopharmacol; 2015 Mar; 25(1):229-34. PubMed ID: 25681283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
    Dentino AR; Raj PA; De Nardin E
    Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retro-all-D and retro isomers of a formyl-methionyl peptide chemoattractant: an insight into the mode of binding at the receptor on rabbit neutrophils.
    Bonora GM; Toniolo C; Freer RJ; Becker EL
    Biochim Biophys Acta; 1986 Dec; 884(3):545-9. PubMed ID: 3778938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.
    Marasco WA; Feltner DE; Ward PA
    J Cell Biochem; 1985; 27(4):359-75. PubMed ID: 2987275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor.
    Dalpiaz A; Ferretti ME; Vertuani G; Traniello S; Scatturin A; Spisani S
    Eur J Pharmacol; 2002 Feb; 436(3):187-96. PubMed ID: 11858798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. fMLP-OMe analogs substituted at the methionine residue: an insight into the receptor properties.
    Cavicchioni G; Monesi LG; Ferretti ME; Fabbri E; Rizzuti O; Spisani S
    Arch Pharm (Weinheim); 1998 Nov; 331(11):368-70. PubMed ID: 9881061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM; Huang CK; Becker EL
    J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
    Borish L; O'Reilly D; Klempner MS; Rocklin RE
    J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages.
    Marceau F; deBlois D; Laplante C; Petitclerc E; Pelletier G; Grose JH; Hugli TE
    Circ Res; 1990 Nov; 67(5):1059-70. PubMed ID: 1699682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.